141 related articles for article (PubMed ID: 21195709)
1. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
Sun BT; Zheng LH; Bao YL; Yu CL; Wu Y; Meng XY; Li YX
Eur J Pharmacol; 2011 Mar; 654(2):129-34. PubMed ID: 21195709
[TBL] [Abstract][Full Text] [Related]
2. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression.
Zheng LH; Bao YL; Wu Y; Yu CL; Meng X; Li YX
Cancer Lett; 2008 Dec; 272(1):102-9. PubMed ID: 18703276
[TBL] [Abstract][Full Text] [Related]
3. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
4. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
5. Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P‑glycoprotein expression.
Sun L; Chen W; Qu L; Wu J; Si J
Mol Med Rep; 2013 Dec; 8(6):1883-7. PubMed ID: 24145579
[TBL] [Abstract][Full Text] [Related]
6. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
Tsang WP; Kwok TT
Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
[TBL] [Abstract][Full Text] [Related]
7. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
Gao P; Zhou GY; Guo LL; Zhang QH; Zhen JH; Fang AJ; Lin XY
Cancer Lett; 2007 Oct; 256(1):81-9. PubMed ID: 17637500
[TBL] [Abstract][Full Text] [Related]
8. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hydro-alcoholic extract of Eclipta alba for its multidrug resistance reversal potential: an in vitro study.
Chaudhary H; Jena PK; Seshadri S
Nutr Cancer; 2013; 65(5):775-80. PubMed ID: 23859045
[TBL] [Abstract][Full Text] [Related]
10. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
[TBL] [Abstract][Full Text] [Related]
11. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.
Wang L; Meng Q; Wang C; Liu Q; Peng J; Huo X; Sun H; Ma X; Liu K
J Nat Prod; 2013 May; 76(5):909-14. PubMed ID: 23621869
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C
Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841
[TBL] [Abstract][Full Text] [Related]
13. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.
Nishanth RP; Ramakrishna BS; Jyotsna RG; Roy KR; Reddy GV; Reddy PK; Reddanna P
Eur J Pharmacol; 2010 Dec; 649(1-3):74-83. PubMed ID: 20858479
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
15. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo.
Guo CB; Li YC; Jin XQ
Cancer Chemother Pharmacol; 2006 Jul; 58(1):40-9. PubMed ID: 16284790
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
17. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
Guo C; Jin X
Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
[TBL] [Abstract][Full Text] [Related]
18. [Reversal of multidrug resistance gene MDR1 and MRP of drug-resistant human hepatocellular carcinoma cells SMMC-7721/ADM with antisense phosphorothioate oligonucleotides].
Luo HY; Yang JY; Liu ZM; Lin QY; Yan LN
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):85-7. PubMed ID: 14980107
[TBL] [Abstract][Full Text] [Related]
19. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
Jia L; Xu H; Zhao Y; Jiang L; Yu J; Zhang J
Cancer Invest; 2008 Dec; 26(10):977-83. PubMed ID: 19093255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]